Key result
Hybrid transfemoral TAVI and transaxillary valve-in-MAC successfully treats severe double-valve disease.
Why the study?
Severe aortic and mitral annular calcifications in high surgical risk patients pose challenges for conventional surgery, necessitating tailored minimally invasive hybrid approaches.
Case Report (n=1)
No
A hybrid transaxillary direct-vision approach offers a feasible and versatile surgical platform for managing high-risk patients with concurrent severe aortic stenosis and severe mitral annular calcification, providing a critical safety margin to resolve complex intraoperative complications like LVOT obstruction.
Supports feasibility of hybrid TAVI/valve-in-MAC in high-risk MAC; hypothesis-generating and requires prospective validation.
Clinical vignetteA 70-year-old female with a history of hypertension, paroxysmal atrial fibrillation, previous ischemic stroke, and extensive atherosclerotic disease was referred to our center for symptomatic severe rheumatic aortic stenosis (mean gradient 43 mmHg) with severe aortic regurgitation and hemodynamically significant rheumatic mitral stenosis (mean gradient 8-9 mmHg).She presented with New York Heart Association (NYHA) class III symptoms, with preserved left ventricular systolic function (LVEF 60%).Preoperative transthoracic echocardiography and multiplanar computed tomography (CT) reconstruction confirmed a heavily calcified aortic valve alongside massive, circumferential calcification of the mitral annulus extending into the posterior leaflet [severe mitral annular calcification (MAC)]; the ascending aorta also exhibited diffuse calcifications.Due to the severe aortic calcifications and the patient's very high surgical risk profile, conventional surgery via full sternotomy was deemed to carry an unfavorable risk-benefit ratio (1).Following a comprehensive Heart Team evaluation, a tailored minimally invasive hybrid surgical strategy was planned: transfemoral transcatheter aortic valve implantation (TAVI) followed by direct transatrial valvein-MAC via a right transaxillary minithoracotomy (2); the latter was selected over a fully percutaneous transseptal approach to allow direct resection of the anterior mitral leaflet [reducing the risk of left ventricular outflow tract (LVOT) obstruction, otherwise predicted on preprocedural CT scan] and to safely manipulate the calcified annulus under direct vision while minimizing systemic calcium embolization risk.Indeed, preoperative CT virtual valve simulation (using 3mensio software) demonstrated a predicted Neo-LVOT area with an intact anterior leaflet critically reduced at 125.9 mm 2 , while the resection would have expanded the predicted Neo-LVOT area to a safe threshold of 240.8 mm 2 .The CT-derived mitral annular area was 8.6 cm 2 .
No takes yet. Share an insight, caveat, or question.
Galeazzi et al. (2026) conducted a case report in Severe rheumatic aortic stenosis and rheumatic mitral stenosis with severe mitral annular calcification (MAC) (n=1). Combined transfemoral TAVI and direct-vision valve-in-MAC via transaxillary approach was evaluated on Procedural success and resolution of symptoms/gradients. A combined transfemoral TAVI and direct-vision valve-in-MAC via a right transaxillary approach successfully treated severe aortic and mitral valvular disease with favorable postoperative hemodynamics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: